Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Environmental Science and Pollution Research International
|
December 16, 2025
Optimizing microbial fuel cells for wastewater treatment: material advances, design strategies, and application frontiers
Sen Wang, Zhiwei Fan, Yanling Guan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 27, 2021
The pathogenesis, models and therapeutic advances of primary biliary cholangitis
Hao Li, Yanling Guan, Chenchen Han, et al.
European Journal of Pharmacology
|
June 17, 2022
Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
Hao Li, Yanling Guan, Bo Liang, et al.
Cellular Signalling
|
March 4, 2025
Paeoniflorin-6'-O-benzene sulfonate inhibits keratinocyte proliferation by restoring GRK2-JAK1 colocalization in mouse model of psoriasis
Tian Tian, Mengzhu Wei, Yanling Guan, et al.
Journal of Hazardous Materials
|
April 1, 2026
Emission characteristics and health risk assessment of oil mist and VOCs in several typical industrial processes
DingChao Zhang, Yuying Li, Xin Wang, et al.
Acta Biochimica Et Biophysica Sinica
|
September 23, 2022
NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease
Yanling Guan, Yiyue Gu, Hao Li, et al.
Food Science & Nutrition
|
September 13, 2023
Effects of antimicrobial peptide and tributyrin on fecal microflora and blood indices of female calves
Junling Gao, Jianan Dong, Zhe Sun, et al.
Cellular Immunology
|
February 7, 2024
The research progression of direct NLRP3 inhibitors to treat inflammatory disorders
Xiu Chen, Pingping Zhang, Yu Zhang, et al.
Infectious Agents and Cancer
|
November 14, 2023
IGFBP2 drives epithelial-mesenchymal transition in hepatocellular carcinoma via activating the Wnt/β-catenin pathway
Xiu Chen, Yu Zhang, Pingping Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 1, 2022
Dominant negative TGF-β receptor type II in T lymphocytes promotes anti-tumor immunity by modulating T cell subsets and enhancing CTL responses
Hao Li, Yanling Guan, Chenchen Han, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Environmental Science and Pollution Research International
|
December 16, 2025
Optimizing microbial fuel cells for wastewater treatment: material advances, design strategies, and application frontiers
Sen Wang, Zhiwei Fan, Yanling Guan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 27, 2021
The pathogenesis, models and therapeutic advances of primary biliary cholangitis
Hao Li, Yanling Guan, Chenchen Han, et al.
European Journal of Pharmacology
|
June 17, 2022
Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
Hao Li, Yanling Guan, Bo Liang, et al.
Cellular Signalling
|
March 4, 2025
Paeoniflorin-6'-O-benzene sulfonate inhibits keratinocyte proliferation by restoring GRK2-JAK1 colocalization in mouse model of psoriasis
Tian Tian, Mengzhu Wei, Yanling Guan, et al.
Journal of Hazardous Materials
|
April 1, 2026
Emission characteristics and health risk assessment of oil mist and VOCs in several typical industrial processes
DingChao Zhang, Yuying Li, Xin Wang, et al.
Acta Biochimica Et Biophysica Sinica
|
September 23, 2022
NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease
Yanling Guan, Yiyue Gu, Hao Li, et al.
Food Science & Nutrition
|
September 13, 2023
Effects of antimicrobial peptide and tributyrin on fecal microflora and blood indices of female calves
Junling Gao, Jianan Dong, Zhe Sun, et al.
Cellular Immunology
|
February 7, 2024
The research progression of direct NLRP3 inhibitors to treat inflammatory disorders
Xiu Chen, Pingping Zhang, Yu Zhang, et al.
Infectious Agents and Cancer
|
November 14, 2023
IGFBP2 drives epithelial-mesenchymal transition in hepatocellular carcinoma via activating the Wnt/β-catenin pathway
Xiu Chen, Yu Zhang, Pingping Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 1, 2022
Dominant negative TGF-β receptor type II in T lymphocytes promotes anti-tumor immunity by modulating T cell subsets and enhancing CTL responses
Hao Li, Yanling Guan, Chenchen Han, et al.
Page
of 2